Popular Stories
RADAR on Medicare Advantage
-
Nearly a year into the massive nationwide effort to reverify Medicaid eligibility after a pause in redeterminations during the COVID-19 pandemic, about 40% of renewals have yet to occur. With...
-
Most seniors are happy with their health benefits, whether they get coverage via Medicare Advantage or traditional Medicare, but some pain points persist across programs. And when it comes to...
HEALTH PLAN WEEKLY
-
During a keynote session at the AHIP Medicare, Medicaid, Duals & Commercial Markets Forum, health plan leaders offered sobering assessments about the state of health equity in the U.S. Still, they offered...
-
The American Academy of Actuaries has urged the Biden administration to follow through on its proposal to rescind a controversial 2018 rule that granted more regulatory leeway to association health plans...
Radar On Speciality Pharmacy
-
The FDA approved the first biosimilar in 2015, and since then, almost 50 more have been greenlighted. Last year saw the biggest influx of these competitors onto the U.S. market, and a recent Cardinal Health...
-
Late last year, the FDA approved a new regimen for urothelial cancer that could transform the treatment of the condition, according to industry experts. However, the cost of the combination — which is estimated...
RADAR ON DRUG BENEFITS
-
Bristol Myers Squibb on March 18 completed its $14 billion acquisition of Karuna Therapeutics, Inc., whose lead drug, KarXT (xanomeline-trospium), is expected to gain FDA approval for treating schizophrenia later...
-
Prescription drug affordability boards (PDABs) have been rising in popularity as a way for states to tamp down on soaring drug prices. But a recent lawsuit filed by one drugmaker and public remarks from the...
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.